COVID-19

Home / COVID-19

COVID-19

How is it Spread?

People can become infected with COVID-19 from others who are infected the virus. Transmission of the virus occurs through small droplets that are spread when a person coughs, sneezes or exhales. These droplets can inadvertently be inhaled or acquired by touching your eyes, nose or mouth after coming in contact with a contaminated surface. The virus may survive on objects or surfaces for up to 3 days. We, therefore, recommend hand-washing thoroughly, avoid touching your face, and maintaining 2 metres (6 feet) while practicing physical distancing.

Signs and Symptoms

The most common symptoms of COVID-19 are fever, tiredness, and dry cough. Some patients may develop body aches and pains, nasal congestion, runny nose, sore throat or diarrhea. About 80% of people who are infected will recover from the disease without needing special treatment. Around 1 out of every 6 people infected with COVID-19 become seriously ill and develop difficulty breathing.

Testing

If you develop symptoms, use the BC COVID-19 Self-Assessment Tool (https://bc.thrive.health/covid19) to help determine if you need further assessment or testing for COVID-19. You can complete this assessment for yourself, or on behalf of someone else, if they are unable to.

Treatments

Currently there are no approved specific treatments or vaccines against COVID-19 infection. For now, treatment is primarily aimed at supporting symptoms.

There are studies investigating treatment options. Click here to read more about a study treatment for those who test positive for COVID-19.

References

COVID-19. BC CDC

COVID-19. European Centre for Disease Prevention and Control

Coronavirus disease 2019. World Health Organization

If you would like to hear more about COVID-19, please click the button below: 

Click here to learn more about the company's policy on COVID-19.

COLCORONA Clinical Trial

The COLCORONA project is a government-funded clinical trial to determine whether a short-term study treatment with an investigational medication reduces the risk of death and lung complications related to COVID-19.

The project involves:

  •  The daily intake of study medication (pill) or placebo for 30 days.
  • 2-3 follow-up calls or video visits.

You must meet the following requirements to be eligible for this trial:

  • Have a COVID-19 positive diagnosis.
  • Be over the age of 40.
  • Not hospitalized.

Individuals in the following categories are excluded:

  • Women who are pregnant, breastfeeding, or not on contraception.

For more information or to take part in the trial, please call 1-877-536-6837.